Variant report

Variant	nsv1064239
Chromosome Location	chr16:32872263-33375872
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:4043)
CpG islands
(count:2135)
Chromatin interactive
region (count:8)
LncRNA
region (count:38)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:4043 , 50 per page) page: 1 2 3 4 5 6 7 ... 81

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:33293788-33294209	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:32876710-32876890	HepG2	liver:	n/a	n/a
3	ATF1	chr16:32873309-32873509	K562	blood:	n/a	n/a
4	ATF3	chr16:32909214-32909368	K562	blood:	n/a	n/a
5	ATF3	chr16:33240952-33241267	HepG2	liver:	n/a	n/a
6	ATF3	chr16:33293710-33294426	HepG2	liver:	n/a	n/a
7	ATF3	chr16:32876765-32876921	K562	blood:	n/a	n/a
8	ATF3	chr16:32993758-32993903	K562	blood:	n/a	n/a
9	BACH1	chr16:33293845-33294023	K562	blood:	n/a	n/a
10	BATF	chr16:33092972-33093212	GM12878	blood:	n/a	n/a
11	BATF	chr16:33369625-33369914	GM12878	blood:	n/a	n/a
12	BATF	chr16:33046042-33046353	GM12878	blood:	n/a	n/a
13	BATF	chr16:33002452-33002671	GM12878	blood:	n/a	n/a
14	BATF	chr16:33087692-33087910	GM12878	blood:	n/a	n/a
15	BATF	chr16:33364185-33364651	GM12878	blood:	n/a	chr16:33364440-33364451
16	BATF	chr16:32909165-32909547	GM12878	blood:	n/a	n/a
17	BATF	chr16:33091390-33091661	GM12878	blood:	n/a	n/a
18	BATF	chr16:33052317-33052590	GM12878	blood:	n/a	n/a
19	BATF	chr16:33082292-33082557	GM12878	blood:	n/a	n/a
20	BATF	chr16:33365611-33366045	GM12878	blood:	n/a	n/a
21	BATF	chr16:33048704-33048907	GM12878	blood:	n/a	n/a
22	BATF	chr16:33165745-33165958	GM12878	blood:	n/a	n/a
23	BATF	chr16:33358267-33358522	GM12878	blood:	n/a	n/a
24	BATF	chr16:33087718-33087908	GM12878	blood:	n/a	n/a
25	BATF	chr16:33365688-33366003	GM12878	blood:	n/a	n/a
26	BATF	chr16:33042432-33043800	GM12878	blood:	n/a	n/a
27	BATF	chr16:33328184-33328483	GM12878	blood:	n/a	chr16:33328300-33328311
28	BATF	chr16:33041862-33042137	GM12878	blood:	n/a	n/a
29	BATF	chr16:33331077-33331251	GM12878	blood:	n/a	n/a
30	BATF	chr16:33044491-33044914	GM12878	blood:	n/a	chr16:33044727-33044738
31	BATF	chr16:33046034-33046402	GM12878	blood:	n/a	n/a
32	BATF	chr16:33044181-33044885	GM12878	blood:	n/a	chr16:33044727-33044738
33	BATF	chr16:33052311-33052561	GM12878	blood:	n/a	n/a
34	BATF	chr16:33042934-33043504	GM12878	blood:	n/a	n/a
35	BATF	chr16:33077153-33077342	GM12878	blood:	n/a	n/a
36	BATF	chr16:32944783-32945170	GM12878	blood:	n/a	n/a
37	BATF	chr16:33042313-33042791	GM12878	blood:	n/a	n/a
38	BATF	chr16:33051517-33051717	GM12878	blood:	n/a	n/a
39	BATF	chr16:33043855-33044053	GM12878	blood:	n/a	n/a
40	BATF	chr16:32993933-32994319	GM12878	blood:	n/a	n/a
41	BATF	chr16:33020846-33021096	GM12878	blood:	n/a	n/a
42	BATF	chr16:33370078-33370545	GM12878	blood:	n/a	n/a
43	BATF	chr16:32951300-32951515	GM12878	blood:	n/a	chr16:32951446-32951457
44	BATF	chr16:33002463-33002715	GM12878	blood:	n/a	n/a
45	BATF	chr16:33051640-33051829	GM12878	blood:	n/a	n/a
46	BCL11A	chr16:33359781-33360055	GM12878	blood:	n/a	n/a
47	BCL11A	chr16:33329783-33329955	GM12878	blood:	n/a	n/a
48	BCL11A	chr16:33091379-33091698	GM12878	blood:	n/a	n/a
49	BCL11A	chr16:33040538-33040783	GM12878	blood:	n/a	chr16:33040559-33040572 chr16:33040559-33040572
50	BCL11A	chr16:33052308-33052584	GM12878	blood:	n/a	n/a

(count:2135 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:33356843-33356893	Hepatocyte	liver:	n/a
2	chr16:33006163-33006213	HCF	heart:	n/a
3	chr16:33318910-33318960	HCT-116	colon:	n/a
4	chr16:33298952-33299002	GM06990	blood:	n/a
5	chr16:33357426-33357476	SKMC	muscle:	n/a
6	chr16:33071657-33071707	Hela-S3	cervix:	n/a
7	chr16:33374131-33374181	HRPEpiC	eye:	n/a
8	chr16:32898433-32898483	AG10803	skin:	n/a
9	chr16:33038922-33038972	AoSMC	blood vessel:	n/a
10	chr16:33039897-33039947	Caco-2	colon:	n/a
11	chr16:33044270-33044320	SAEC	small airway:	n/a
12	chr16:33356843-33356893	HCT-116	colon:	n/a
13	chr16:33357151-33357201	K562	blood:	n/a
14	chr16:33374161-33374211	GM19239	blood:	n/a
15	chr16:32895392-32895442	GM12892	blood:	n/a
16	chr16:33358227-33358277	BE2_C	brain:	n/a
17	chr16:32937057-32937107	NH-A	brain:	n/a
18	chr16:33357151-33357201	ECC-1	luminal epithelium:	n/a
19	chr16:33038922-33038972	HEK293	kidney:	embryo
20	chr16:33038657-33038707	GM12891	blood:	n/a
21	chr16:33356843-33356893	Caco-2	colon:	n/a
22	chr16:32940983-32941033	HCT-116	colon:	n/a
23	chr16:33319362-33319412	CMK	blood:	n/a
24	chr16:33318910-33318960	HL-60	blood:	n/a
25	chr16:33374028-33374078	HCPEpiC	choroid plexus:	n/a
26	chr16:33319362-33319412	AG09309	skin:	n/a
27	chr16:32936895-32936945	SK-N-SH	brain:	n/a
28	chr16:33318910-33318960	SK-N-SH_RA	brain:	n/a
29	chr16:33302523-33302573	HIPEpiC	eye:	n/a
30	chr16:33317852-33317902	HCPEpiC	choroid plexus:	n/a
31	chr16:33319610-33319660	HRE	kidney:	n/a
32	chr16:32934020-32934070	PrEC	prostate:	n/a
33	chr16:33006163-33006213	Hela-S3	cervix:	n/a
34	chr16:33038657-33038707	HRCEpiC	kidney:	n/a
35	chr16:33374131-33374181	IMR90	lung:	fetal
36	chr16:33259538-33259588	AoSMC	blood vessel:	n/a
37	chr16:33302523-33302573	AoSMC	blood vessel:	n/a
38	chr16:33297688-33297738	AG09319	gingival:	n/a
39	chr16:32937057-32937107	NHDF-neo	bronchial:	n/a
40	chr16:33318910-33318960	T-47D	breast:	n/a
41	chr16:33319353-33319403	SKMC	muscle:	n/a
42	chr16:33040275-33040325	MCF-7	breast:	n/a
43	chr16:32936895-32936945	HCPEpiC	choroid plexus:	n/a
44	chr16:33038657-33038707	AG09319	gingival:	n/a
45	chr16:32936664-32936714	NB4	blood:	n/a
46	chr16:33038657-33038707	NHBE	bronchial:	n/a
47	chr16:33374131-33374181	HPAEpiC	pulmonary alveolar:	n/a
48	chr16:33040275-33040325	HEK293	kidney:	embryo
49	chr16:33319610-33319660	SKMC	muscle:	n/a
50	chr16:33070632-33070682	AoSMC	blood vessel:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:32876653..32877208-chr16:33618895..33619446,2	MCF-7	breast:
2	chr16:32993835..32994354-chr16:33619041..33619624,2	MCF-7	breast:
3	chr16:33357445..33357965-chrX:123093937..123094556,2	MCF-7	breast:
4	chr16:33374454..33377112-chr16:33390580..33392185,2	MCF-7	breast:
5	chr16:33362493..33363428-chr3:73095698..73096500,2	MCF-7	breast:
6	chr16:32951293..32951850-chr16:33618657..33619267,2	MCF-7	breast:
7	chr16:32876380..32877212-chr16:32951315..32951834,2	MCF-7	breast:
8	chr16:32876380..32877212-chr16:32951315..32951834,2	MCF-7	breast:

(count:38 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC136428.1.1-6	chr16:33217752-33218127	ENSG00000261507.1
2	lnc-RP11-1277H1.1.1-11	chr16:32926395-32926440	NONHSAT142052
3	lnc-RP11-1277H1.1.1-4	chr16:32897547-32898093	ENSG00000214614.2
4	lnc-CTD-2144E22.5.1-37	chr16:33262848-33262894	NONHSAT142077
5	lnc-RP11-1277H1.1.1-4	chr16:32899139-32900195	ENSG00000214614.2
6	lnc-AC136428.1.1-7	chr16:33206606-33206675	ENSG00000260419.1
7	lnc-AC136428.1.1-4	chr16:33337232-33337443	ENSG00000260626.1
8	lnc-RP11-1277H1.1.1-2	chr16:33342943-33343609	XLOC_011696
9	lnc-RP11-1277H1.1.1-4	chr16:32898658-32899949	ENSG00000214614.2
10	lnc-AC136428.1.1-5	chr16:33271714-33272098	ENSG00000261009.1
11	lnc-AC136428.1.1-6	chr16:33231506-33231583	ENSG00000261507.1
12	lnc-RP11-1277H1.1.1-4	chr16:32897778-32897912	ENSG00000214614.2
13	lnc-RP11-1277H1.1.1-1	chr16:33145040-33145820	ENSG00000261682.1
14	lnc-RP11-1277H1.1.1-11	chr16:32926544-32926857	NONHSAT142052
15	lnc-TP53TG3-17	chr16:32943089-32943890	NONHSAT142053
16	lnc-TP53TG3-5	chr16:33102620-33102910	ENSG00000260141.1
17	lnc-AC136428.1.1-6	chr16:33216015-33216055	ENSG00000260827.1
18	lnc-RP11-1277H1.1.1-4	chr16:32896515-32896578	ENSG00000214614.2
19	lnc-RP11-1277H1.1.1-9	chr16:32989910-32990212	NONHSAT142058
20	lnc-AC136428.1.1-7	chr16:33202882-33203073	ENSG00000260419.1
21	lnc-AC136428.1.1-4	chr16:33336283-33336630	ENSG00000260626.1
22	lnc-CTD-2144E22.5.1-37	chr16:33263182-33263470	NONHSAT142077
23	lnc-AC136428.1.1-5	chr16:33272554-33272594	ENSG00000261009.1
24	lnc-RP11-1277H1.1.1-3	chr16:33006858-33006938	ENSG00000260921.1
25	lnc-RP11-1277H1.1.1-7	chr16:33141556-33141763	NONHSAT142067
26	lnc-RP11-1277H1.1.1-9	chr16:32989782-32989827	NONHSAT142058
27	lnc-RP11-1277H1.1.1-4	chr16:32897796-32898008	ENSG00000214614.2
28	lnc-AC136428.1.1-6	chr16:33215175-33215559	ENSG00000260827.1
29	lnc-TP53TG3-5	chr16:33054930-33055459	ENSG00000260141.1
30	lnc-AC136428.1.1-6	chr16:33231324-33231409	ENSG00000261507.1
31	lnc-RP11-1277H1.1.1-4	chr16:32898658-32898880	ENSG00000214614.2
32	lnc-RP11-1277H1.1.1-3	chr16:33007112-33007188	ENSG00000260921.1
33	lnc-RP11-1277H1.1.1-2	chr16:33340193-33341795	XLOC_011696
34	lnc-RP11-1277H1.1.1-4	chr16:32898371-32898495	ENSG00000214614.2
35	lnc-RP11-1277H1.1.1-4	chr16:32898658-32898850	ENSG00000214614.2
36	lnc-CTD-2144E22.5.1-37	chr16:33263683-33264006	NONHSAT142077
37	lnc-RP11-1277H1.1.1-1	chr16:33140637-33140721	ENSG00000261682.1
38	lnc-RP11-1277H1.1.1-3	chr16:33007600-33008091	ENSG00000260921.1

No data

Variant related genes	Relation type
IGHV3OR16-8	TF binding region
ENSG00000260414	TF binding region
ENSG00000263277	TF binding region
ENSG00000261682	TF binding region
ENSG00000261466	TF binding region
ENSG00000261405	TF binding region
ENSG00000261507	TF binding region
ENSG00000260610	TF binding region
IGHV3OR16-15	TF binding region
ENSG00000261009	TF binding region
TP53TG3C	TF binding region
ENSG00000263337	TF binding region
ENSG00000260419	TF binding region
ENSG00000262090	TF binding region
ENSG00000214614	TF binding region
IGHV3OR16-10	TF binding region
ENSG00000260047	TF binding region
ENSG00000260827	TF binding region
SLC6A10P	TF binding region
ENSG00000261259	TF binding region
ENSG00000260626	TF binding region
IGHV1OR16-2	TF binding region
TP53TG3B	TF binding region
ENSG00000263204	TF binding region
ENSG00000261536	TF binding region
IGHV3OR16-6	TF binding region
ENSG00000261200	TF binding region
ENSG00000260141	TF binding region
ENSG00000260921	TF binding region
ENSG00000260900	TF binding region
ENSG00000259800	TF binding region
IGHV1OR16-4	TF binding region
HERC2P8	TF binding region
IGHV3OR16-8	CpG island
ENSG00000260414	CpG island
ENSG00000263277	CpG island
ENSG00000261682	CpG island
ENSG00000261466	CpG island
ENSG00000261405	CpG island
ENSG00000261507	CpG island
ENSG00000260610	CpG island
IGHV3OR16-15	CpG island
ENSG00000261009	CpG island
TP53TG3C	CpG island
ENSG00000263337	CpG island
ENSG00000260419	CpG island
ENSG00000262090	CpG island
ENSG00000214614	CpG island
IGHV3OR16-10	CpG island
ENSG00000260047	CpG island
ENSG00000260827	CpG island
SLC6A10P	CpG island
ENSG00000261259	CpG island
ENSG00000260626	CpG island
IGHV1OR16-2	CpG island
TP53TG3B	CpG island
ENSG00000263204	CpG island
ENSG00000261536	CpG island
IGHV3OR16-6	CpG island
ENSG00000261200	CpG island
ENSG00000260141	CpG island
ENSG00000260921	CpG island
ENSG00000260900	CpG island
ENSG00000259800	CpG island
IGHV1OR16-4	CpG island
HERC2P8	CpG island
ENSG00000101972	chromatin interactions
UHMK1	miRNA target sites

Extended variants
information (count: 3511 )
Associated
traits (count: 131 )

Variant overlapped rSNPs/rCNVs (count:3511 , 50 per page) page: 1 2 3 4 5 6 7 ... 71

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558586481	chr16:32876601-32876602	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs1651608	chr16:32876656-32876657	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs576927644	chr16:32876704-32876705	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs191615604	chr16:32876794-32876795	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs3097301	chr16:32876795-32876796	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs3094331	chr16:32876811-32876812	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs3097302	chr16:32876828-32876829	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs575009382	chr16:32876834-32876835	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs542135163	chr16:32876850-32876851	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs183473680	chr16:32876852-32876853	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs527244532	chr16:32876870-32876871	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs188851544	chr16:32876873-32876874	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs564119647	chr16:32876898-32876899	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs116810617	chr16:32876899-32876900	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs201969105	chr16:32876966-32876967	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs568140224	chr16:32877011-32877012	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs529107996	chr16:32877027-32877028	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs547340685	chr16:32877028-32877029	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs78041799	chr16:32877041-32877042	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs565647352	chr16:32877078-32877079	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs533886515	chr16:32877096-32877097	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs558525447	chr16:32877122-32877123	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs570551302	chr16:32877139-32877140	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs2905124	chr16:32877165-32877166	Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs144312071	chr16:32877208-32877209	Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs148453648	chr16:32877251-32877252	Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs1820207	chr16:32877271-32877272	Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs556644122	chr16:32877292-32877293	Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs113579091	chr16:32877360-32877361	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs201718499	chr16:32877363-32877364	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs11860281	chr16:32877387-32877388	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs1989495	chr16:32877390-32877391	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs150985109	chr16:32877426-32877427	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs542422673	chr16:32877435-32877436	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs1820772	chr16:32877436-32877437	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs683980	chr16:32877457-32877458	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs554463055	chr16:32877478-32877479	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs572776713	chr16:32877484-32877485	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs1794032	chr16:32877488-32877489	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs564057930	chr16:32877501-32877502	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs374348342	chr16:32877536-32877537	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs544862473	chr16:32877537-32877538	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs1794031	chr16:32877540-32877541	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs193216934	chr16:32877549-32877550	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs561838735	chr16:32877593-32877594	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs529039686	chr16:32877605-32877606	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs587210	chr16:32877629-32877630	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs1651609	chr16:32877630-32877631	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs565584578	chr16:32877658-32877659	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs1651610	chr16:32877668-32877669	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:131)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Ductal carcinoma	22052326	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Sezary syndrome	18413736	CNVD
Wilms tumour	21544195	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164920	CNVD
Autism	19287141	CNVD
Schizophrenia	20967226	CNVD
Breast cancer	17142309	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD
Lung cancer	18438408	CNVD
Autism	21865298	CNVD
Breast cancer	21509527	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Melanoma	20877625	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:277 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:32876600-32876800	Enhancers	Skeletal Muscle Female	skeletal muscle
2	chr16:32876800-32877000	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr16:32876800-32877000	Enhancers	Skeletal Muscle Male	skeletal muscle
4	chr16:32876800-32877200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
5	chr16:32876800-32881000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
6	chr16:32877000-32877400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
7	chr16:32877200-32877400	Active TSS	Skeletal Muscle Female	skeletal muscle
8	chr16:32877400-32877600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
9	chr16:32877400-32877800	Enhancers	Skeletal Muscle Male	skeletal muscle
10	chr16:32877600-32877800	Active TSS	Skeletal Muscle Female	skeletal muscle
11	chr16:32877800-32878000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
12	chr16:32877800-32878200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
13	chr16:32878000-32878200	Active TSS	Skeletal Muscle Female	skeletal muscle
14	chr16:32878200-32878600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
15	chr16:32878200-32880000	Active TSS	Skeletal Muscle Male	skeletal muscle
16	chr16:32878600-32879400	Active TSS	Skeletal Muscle Female	skeletal muscle
17	chr16:32879400-32879800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
18	chr16:32879800-32880200	Enhancers	Left Ventricle	heart
19	chr16:32879800-32881000	Enhancers	Skeletal Muscle Female	skeletal muscle
20	chr16:32880000-32880800	Enhancers	Skeletal Muscle Male	skeletal muscle
21	chr16:32880800-32883800	Weak transcription	Skeletal Muscle Male	skeletal muscle
22	chr16:32881000-32881800	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr16:32881000-32886000	Weak transcription	Skeletal Muscle Female	skeletal muscle
24	chr16:32883800-32884200	Enhancers	Skeletal Muscle Male	skeletal muscle
25	chr16:32884200-32885400	Weak transcription	Skeletal Muscle Male	skeletal muscle
26	chr16:32885400-32887600	Enhancers	Skeletal Muscle Male	skeletal muscle
27	chr16:32886000-32887400	Enhancers	Skeletal Muscle Female	skeletal muscle
28	chr16:32890600-32891000	Active TSS	HSMM	muscle
29	chr16:32957400-32957800	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr16:33006000-33007200	Enhancers	Dnd41	blood
31	chr16:33039600-33040000	Bivalent Enhancer	Placenta	Placenta
32	chr16:33039600-33040800	Active TSS	K562	blood
33	chr16:33040000-33040400	Flanking Bivalent TSS/Enh	Placenta	Placenta
34	chr16:33040400-33040800	Bivalent Enhancer	Placenta	Placenta
35	chr16:33070400-33071000	Bivalent Enhancer	Placenta	Placenta
36	chr16:33070600-33071000	Active TSS	Psoas Muscle	Psoas
37	chr16:33070800-33071000	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr16:33071400-33071600	Enhancers	Right Ventricle	heart
39	chr16:33140000-33140400	Active TSS	HSMM	muscle
40	chr16:33140200-33140400	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr16:33140200-33140400	Enhancers	Brain Inferior Temporal Lobe	brain
42	chr16:33236400-33241000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr16:33236600-33241600	Weak transcription	Fetal Lung	lung
44	chr16:33237400-33237600	Bivalent Enhancer	Placenta	Placenta
45	chr16:33237400-33237600	Enhancers	Right Ventricle	heart
46	chr16:33237400-33238000	Active TSS	Primary T helper naive cells from peripheral blood	blood
47	chr16:33237400-33238000	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr16:33237400-33238200	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
49	chr16:33237400-33238200	Active TSS	Primary T cells from cord blood	blood
50	chr16:33237400-33238200	ZNF genes & repeats	Duodenum Smooth Muscle	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links